Position in DXCM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$462,565,861
-$20,789,791 QoQ
Shares Held
6,868,090
-5.7% QoQ
Ownership
1.82%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#12
of 951 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026NORGES BANK holds $8,506,007,933 across 26 Medical Devices names. DXCM ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
23,354,911 | $2,119,224,624 | |
| 2 | SYK |
Stryker Corp
|
4,892,615 | $1,540,390,906 | |
| 3 | MDT |
Medtronic plc
|
16,551,016 | $1,294,785,981 | |
| 4 | BSX |
Boston Scientific Corp
|
21,170,029 | $903,536,837 | |
| 5 | EW |
Edwards Lifesciences Corp
|
8,373,783 | $757,492,410 | |
| 6 | DXCM |
Dexcom Inc
This page
|
6,868,090 | $462,565,861 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
5,823,524 | $372,763,771 | |
| 8 | STE |
STERIS plc
|
1,192,173 | $251,035,868 |
All Filings in DXCM
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $462,565,861 | 6,868,090 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $483,355,652 | 7,282,743 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $453,279,162 | 5,192,796 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $335,082,572 | 4,906,759 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $385,366,526 | 4,955,208 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $335,475,534 | 5,004,110 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $611,042,802 | 5,389,335 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $724,957,992 | 5,226,806 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $540,177,668 | 4,353,112 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $374,459,456 | 4,013,499 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $511,156,107 | 3,977,559 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $435,255,590 | 3,746,390 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $421,377,816 | 3,721,104 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $272,927,911 | 3,388,725 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $247,267,882 | 3,317,696 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $403,450,318 | 788,605 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $410,670,099 | 764,820 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $408,793,708 | 747,529 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $329,254,149 | 771,087 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $265,840,783 | 739,700 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $283,445,098 | 766,648 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $294,298,829 | 713,919 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $254,683,631 | 628,228 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $228,197,708 | 847,468 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||